A型肉毒毒素在美容领域的新用途综述
本文综述A型肉毒毒素(BoNT-A)在美容领域的新用途,包括改善面部皱纹之外的瘢痕、痤疮、玫瑰痤疮、银屑病及神经肌肉疼痛等。作者讨论其原理及已发表的病例研究和临床试验结果,指出这些领域前景良好,但仍需更多更大规模临床研究才能成为临床现实。
要点
- BoNT-A除眉间纹外,还广泛超适应症用于面部其他皱纹。
- BoNT-A可改善增生性瘢痕和瘢痕疙瘩外观,甚至可能预防其发生。
- BoNT-A注射可减轻痤疮、玫瑰痤疮、银屑病症状及神经肌肉疼痛。
核心结论
- BoNT-A在瘢痕、皮肤疾病及疼痛等领域显示初步前景,但需更多更大规模临床研究验证。
研究设计与样本
- 综述,检索并汇总已发表的病例研究和临床试验结果,并列出主要临床试验数据库中相关试验。
主要发现
- BoNT-A用于改善增生性瘢痕和瘢痕疙瘩及预防瘢痕的研究已开展,涉及身体不同部位。
- BoNT-A注射可减少痤疮、玫瑰痤疮和银屑病的体征和症状。
- BoNT-A注射可减轻神经肌肉疼痛,并对由多汗症引起或加重的罕见病有显著改善。
临床怎么用
- 可考虑将BoNT-A用于瘢痕防治及痤疮、玫瑰痤疮、银屑病等辅助治疗,但需基于现有证据谨慎选择患者。
- 可通过BoNT-A与其他美容操作联合、根据肌肉量调整剂量及采用新型注射技术来扩大适用人群。
局限性
- 现有证据多来自病例研究和临床试验,尚需更多更大规模临床研究确认疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BotulinumtoxinA (BoNT-A) is now widely established for the main approved indication of reducing glabellar lines, and is also widely used off-label to improve the appearance of wrinkles and lines in other parts of the face. The number of aesthetic procedures continues to increase as the patient population becomes more diverse, in particular with increasing numbers of people of color and men. Further developments in treatment may continue to expand the audience for BoNT-A by making procedures more comfortable and by delivering a more natural, less static appearance. These may be achieved through use of combinations of BoNT-A with other aesthetic procedures, tailoring the dose of toxin to the patient's muscle mass or by using novel injection and application techniques. Beyond amelioration of facial lines, encouraging results have been seen with the use of BoNT-A to improve the appearance of hypertrophic and keloid scars and even to prevent them. Studies have been conducted with scars in various parts of the body and further research is ongoing. Dermatological and other medical uses for BoNT-A are also active areas of research. Injections of BoNT-A have been shown to reduce signs and symptoms of acne, rosacea, and psoriasis, to reduce neuromuscular pain, and to bring about significant improvements in a number of rare diseases that are caused or exacerbated by hyperhidrosis. This paper reviews these new uses for BoNT-A, looking at the rationale for their use and discussing the results of published case studies and clinical trials. These areas have shown great promise to date, but more and larger clinical studies will be required before these treatments become a clinical reality. To this end details are also provided of clinical trials currently listed in the main clinical trials database to highlight research areas of particular interest.
引用
- Schlessinger J, Gilbert E, Cohen JL, et al. New Uses of AbobotulinumtoxinA in Aesthetics. Aesthet Surg J. 2017. PMID: 28388720. doi:10.1093/asj/sjx005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。